March 27, 2013
Pfizer Inc. has launched suit in New Jersey federal court accusing generic-drug maker Lupin Ltd. of infringing Pfizer's patents for the overactive-bladder drug Detrol LA by seeking federal approval to make a generic version before the patents expire.